Professor Andrea Malaspina has extensive clinical expertise in neuromuscular disorders and a track-record of research in biological mechanisms and biomarkers of neurodegeneration. He completed his specialist training in Neurology and a PhD in Molecular Neurobiology at Imperial College London in 2021. He has been a Consultant Neurologist at Barts Health since 2002, with an active role in Clinical Neurology and research interests in neuromuscular and neurodegenerative disorders. In 2009, he has founded the Royal London (now Barts Health) MND Care and Research Centre. He has been the MND Research Director for DeNDRoN and for the LCRN North-Thames. In 2012, he took up a formal academic appointment as Clinical Senior Lecturer with the Barts and The London Medical School and in 2015 he became Reader in Clinical Neurology. In 2019, as Professor of Neurology, he established the neurodegeneration group at the Blizard Institute. He has been recently appointed Clinical and Academic Lead of the newly created ALS Centre at the National Hospital for Neurology and Neurosurgery (Queen Square Motor Neuron Disease Centre). His focus on patient’s care and research has supported a portfolio of research projects, teaching modules, nation-wide and international biobanking projects and public engagement activities.